Literature DB >> 29408835

Incidence and Factors Correlating With Incisional Hernia Following Open Bowel Resection in Patients With Inflammatory Bowel Disease: A Review of 1000 Patients.

Tomas M Heimann1, Santosh Swaminathan, Adrian J Greenstein, Randolph M Steinhagen.   

Abstract

OBJECTIVE: The aim of this study was to identify the incidence and factors associated with the development of incisional hernia (IH) in patients with inflammatory bowel disease (IBD) undergoing open bowel resections.
BACKGROUND: Predisposing factors for IH have not been well studied in patients with IBD undergoing open bowel resection. The role of duration of the disease, nutritional factors, anti-inflammatory treatment, previous operative procedures, wound infection, and other complicating factors remains unclear.
METHODS: One thousand patients with ulcerative colitis and Crohn's disease were followed for a mean of 8 years after open bowel resection. The incidence of IH was recorded as well as correlating factors with the development of IH.
RESULTS: The overall incidence of IH in this series was 20% (21% for ulcerative colitis and 20% for Crohn's disease). Statistically significant risk factors for development of IH were wound infection (HR 3.66, P <0.001), hypoalbuminemia (HR 2.02, P = 0.002), history of previous bowel resection (HR 1.60, P = 0.003), creation of ileostomy at the time of procedure (HR 1.53, P = 0.01), history of smoking (HR 1.52, P = 0.013), body mass index at surgery (1.036, P = 0.009), age at surgery (HR 1.021, P <0.001), and age at the onset of disease (HR 1.018, P <0.001).
CONCLUSIONS: Patients with IBD have a high incidence of incisional hernia after open bowel resection. Wound infection had the strongest correlation with the development of IH. The other factors were age at onset of IBD, age at surgery, body mass index, serum albumin, presence of ileostomy, previous surgical procedures, and history of smoking. Duration of disease, preoperative steroids, immunosuppressive therapy, and blood transfusion were not found to correlate with IH.

Entities:  

Mesh:

Year:  2018        PMID: 29408835     DOI: 10.1097/SLA.0000000000002120

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  5 in total

1.  Risk of post-operative surgical site infections after vedolizumab vs anti-tumour necrosis factor therapy: a propensity score matching analysis in inflammatory bowel disease.

Authors:  K T Park; L Sceats; M Dehghan; A W Trickey; A Wren; J J Wong; R Bensen; B N Limketkai; K Keyashian; C Kin
Journal:  Aliment Pharmacol Ther       Date:  2018-06-07       Impact factor: 8.171

2.  Abdominal hernia mesh repair in patients with inflammatory bowel disease: A systematic review.

Authors:  Michael El Boghdady; Béatrice Marianne Ewalds-Kvist; Aggelos Laliotis
Journal:  Langenbecks Arch Surg       Date:  2022-08-10       Impact factor: 2.895

Review 3.  Systematic review and meta-analysis: association between obesity/overweight and surgical complications in IBD.

Authors:  Ke Jiang; Bangsheng Chen; Dandi Lou; Mengting Zhang; Yetan Shi; Wei Dai; Jingyi Shen; Bin Zhou; Jinxing Hu
Journal:  Int J Colorectal Dis       Date:  2022-05-31       Impact factor: 2.796

4.  Short-term outcomes and healthcare resource utilization following incisional hernia repair with synthetic mesh in patients with Crohn's disease.

Authors:  B C Perlmutter; H Alkhatib; A L Lightner; A Fafaj; S J Zolin; C C Petro; D M Krpata; A S Prabhu; S D Holubar; M J Rosen
Journal:  Hernia       Date:  2021-08-03       Impact factor: 4.739

5.  Prophylactic retromuscular mesh placement for parastomal hernia prevention: a retrospective cohort study of permanent colostomies and ileostomies.

Authors:  Jonathan Frigault; Simon Lemieux; Dominic Breton; Philippe Bouchard; Alexandre Bouchard; Roger C Grégoire; François Letarte; Gilles Bouchard; Vincent Boun; Katia Massé; Sébastien Drolet
Journal:  Hernia       Date:  2021-06-16       Impact factor: 4.739

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.